- Home
- WNW vs NNVC Comparison
WNW vs NNVC Comparison
Compare WNW & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WNW | NNVC |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.8M | 24.7M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | WNW | NNVC |
|---|---|---|
| Price | $1.50 | $1.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 73.6K | ★ 359.6K |
| Earning Date | 12-04-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | ★ $2,550,178.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.23 | ★ N/A |
| Revenue Growth | ★ 570.49 | N/A |
| 52 Week Low | $0.95 | $0.94 |
| 52 Week High | $70.00 | $2.23 |
Technical Indicators
Market Signals| Indicator | WNW | NNVC |
|---|---|---|
| Relative Strength Index (RSI) | 48.43 | 44.70 |
| Support Level | $1.44 | $1.07 |
| Resistance Level | $1.59 | $1.28 |
| Average True Range (ATR) | 0.18 | 0.11 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 71.54 | 42.31 |
Price Performance
Historical ComparisonAbout WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.